PARKE-DAVIS FDA Approval ANDA 084349

ANDA 084349

PARKE-DAVIS

FDA Drug Application

Application #084349

Documents

Letter2014-03-06
Letter2013-08-08
Letter2014-03-06
Letter2012-12-06
Letter2015-04-23
Label2009-10-19
Label2014-03-06
Label2011-05-06
Label2012-11-30
Label2013-09-19
Label2014-03-06
Label2014-07-29
Label2015-04-23
Review2012-03-28
Label2017-04-19
Label2018-01-26
Label2018-01-26
Label2018-01-26
Label2018-12-27
Medication Guide2018-12-27
Label2020-10-01
Letter2020-10-02
Label2021-11-16
Medication Guide2021-11-16
Medication Guide2022-10-06
Label2022-10-06

Application Sponsors

ANDA 084349PARKE-DAVIS

Marketing Status

Prescription001
Prescription002

Application Products

001CAPSULE;ORAL30MG EXTENDED0DILANTINPHENYTOIN SODIUM
002CAPSULE;ORAL100MG EXTENDED0DILANTINPHENYTOIN SODIUM

FDA Submissions

ORIG1AP1976-08-27
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1982-05-27
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1982-06-02
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1982-06-02
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1982-05-18
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1984-04-09
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1984-04-09
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1984-04-09
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1984-06-14
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1986-10-15
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1986-02-11
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1988-08-25
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1988-08-25
BIOEQUIV; BioequivalenceSUPPL26AP1990-03-22
MANUF (CMC); Manufacturing (CMC)SUPPL30AP1993-11-15
MANUF (CMC); Manufacturing (CMC)SUPPL31AP1997-02-12
MANUF (CMC); Manufacturing (CMC)SUPPL33AP1997-02-11
MANUF (CMC); Manufacturing (CMC)SUPPL34AP1997-04-03
MANUF (CMC); Manufacturing (CMC)SUPPL35AP1996-09-19
MANUF (CMC); Manufacturing (CMC)SUPPL37AP1998-03-25
MANUF (CMC); Manufacturing (CMC)SUPPL38AP1998-03-25
LABELING; LabelingSUPPL40AP2003-12-09
LABELING; LabelingSUPPL41AP2007-08-08
MANUF (CMC); Manufacturing (CMC)SUPPL45AP2007-08-08
LABELING; LabelingSUPPL56AP2009-07-09
LABELING; LabelingSUPPL60AP2009-05-06
LABELING; LabelingSUPPL62AP2014-02-27
REMS; REMSSUPPL64AP2011-04-08
LABELING; LabelingSUPPL67AP2012-11-27
LABELING; LabelingSUPPL70AP2013-08-06STANDARD
LABELING; LabelingSUPPL71AP2013-12-26STANDARD
LABELING; LabelingSUPPL72AP2014-02-27STANDARD
LABELING; LabelingSUPPL73AP2014-07-03STANDARD
LABELING; LabelingSUPPL74AP2015-04-16STANDARD
LABELING; LabelingSUPPL75AP2017-02-01STANDARD
LABELING; LabelingSUPPL77AP2017-02-01STANDARD
LABELING; LabelingSUPPL78AP2017-02-01STANDARD
LABELING; LabelingSUPPL79AP2017-02-01STANDARD
LABELING; LabelingSUPPL80AP2017-02-01STANDARD
LABELING; LabelingSUPPL81AP2017-12-22STANDARD
LABELING; LabelingSUPPL82AP2017-12-22STANDARD
LABELING; LabelingSUPPL84AP2017-12-22STANDARD
LABELING; LabelingSUPPL85AP2018-12-03STANDARD
LABELING; LabelingSUPPL86AP2020-08-07STANDARD
LABELING; LabelingSUPPL87AP2021-10-22STANDARD
LABELING; LabelingSUPPL88AP2022-09-07STANDARD

Submissions Property Types

SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL19Null0
SUPPL20Null0
SUPPL23Null0
SUPPL24Null0
SUPPL26Null0
SUPPL30Null0
SUPPL31Null0
SUPPL33Null0
SUPPL34Null0
SUPPL35Null0
SUPPL37Null0
SUPPL38Null0
SUPPL45Null0
SUPPL60Null7
SUPPL62Null15
SUPPL67Null15
SUPPL70Null15
SUPPL71Null15
SUPPL72Null31
SUPPL73Null15
SUPPL74Null15
SUPPL75Null7
SUPPL77Null15
SUPPL78Null7
SUPPL79Null7
SUPPL80Null7
SUPPL81Null15
SUPPL82Null15
SUPPL84Null15
SUPPL85Null15
SUPPL86Null7
SUPPL87Null7
SUPPL88Null7

TE Codes

002PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 84349
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.